Jack Yalowich

7PUBLICATIONS
12CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsCell and nuclear divisionMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2025
Targeting the DNA damage response through TBL1X in mantle cell lymphoma.

Betsy Pray, Ethan Baiocchi, Sydney Leon

|May 08, 2024
Circumvention of Topoisomerase IIα Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells.

Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao

|Mar 20, 2024
Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase IIβ in Human Leukemia K562 Cells: Generation of a Resistance Phenotype.

Jessika Carvajal-Moreno, Xinyi Wang, Victor A Hernandez

|Sep 19, 2023
Novel bacterial topoisomerase inhibitors: unique targeting activities of amide enzyme-binding motifs for tricyclic analogs.

Chelsea A Mann, Jessika J Carvajal Moreno, Yanran Lu

|Aug 12, 2023
Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks.

Soziema E Dauda, Jessica A Collins, Jo Ann W Byl

|Nov 21, 2022
Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIβ Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide.

Jessika Carvajal-Moreno, Victor A Hernandez, Xinyi Wang

Pageof 2

Frequent Collaborators

4 joint publications

Terry S Elton

1 joint publications

Jessica A Collins

1 joint publications

Neil Osheroff

1 joint publications

Mark J Mitton-Fry